Bipolar disorder involves measurable changes in brain structure, chemical signaling, energy production, and the connections between regions that regulate emotion. It’s not simply a matter of mood swings. The brains of people with bipolar disorder show reduced gray matter in key areas, disrupted communication between emotional and reasoning centers, increased inflammation, and problems at the cellular level that shift with each mood state.
Structural Changes in Gray Matter
Brain imaging studies consistently show that people with bipolar disorder have less gray matter volume in several regions compared to healthy controls. The largest reductions appear in the superior frontal gyrus, a strip along the top of the frontal lobe involved in self-awareness and higher-level thinking. Significant reductions also show up in the anterior cingulate cortex, which helps evaluate emotional information, and the insula, a region tucked deep within each hemisphere that integrates bodily sensations with emotional experience.
People with bipolar I (the type involving full manic episodes) tend to show the most pronounced changes, particularly in the right insula and the inferior frontal gyrus, areas that contribute to impulse control and emotional awareness. Cortical thinning, meaning the outer layer of the brain is physically thinner than expected, has also been documented in the prefrontal cortex and sensory processing areas. These aren’t subtle findings visible only through advanced statistics. They represent real, measurable differences in the physical architecture of the brain.
A Broken Brake Pedal for Emotions
The prefrontal cortex acts as the brain’s executive manager, responsible for reasoning, planning, and keeping emotional reactions in check. The amygdala, by contrast, is the brain’s alarm system, firing rapidly in response to threats, rewards, and emotionally charged situations. In a healthy brain, the prefrontal cortex communicates with the amygdala to dial emotional responses up or down as needed. In bipolar disorder, that communication goes wrong.
Specifically, the medial prefrontal cortex (the inner surface of the frontal lobe) shows reduced connectivity with the rest of the prefrontal network, essentially becoming partially disconnected from the broader reasoning system. At the same time, the connection between the amygdala and this same medial prefrontal region becomes abnormally strong. In healthy brains, that connection is relatively quiet. In bipolar disorder, it’s overactive, meaning emotional signals flood a region that’s already poorly connected to the cognitive control centers that would normally regulate them.
Meanwhile, the connection between the amygdala and the lateral prefrontal cortex, the part of the frontal lobe most involved in deliberate, rational thought, becomes weaker. The net result is a brain where emotional signals are amplified and the systems meant to modulate those signals are undermined. This pattern is especially pronounced in people who have experienced psychotic symptoms during mood episodes.
Cellular Energy Problems That Shift With Mood
Every neuron in the brain depends on mitochondria, tiny structures inside cells that convert nutrients into usable energy. In bipolar disorder, mitochondria don’t function normally. They produce energy less efficiently and generate excess free radicals, reactive molecules that damage DNA, proteins, and cell membranes over time. This creates a cycle: damaged mitochondria produce less energy and more waste, which damages them further.
What makes this especially relevant to bipolar disorder is that mitochondrial activity appears to follow a biphasic pattern tied to mood state. During mania, mitochondrial activity ramps up, flooding neurons with energy and potentially driving the racing thoughts, reduced need for sleep, and heightened drive that characterize manic episodes. During depressive episodes, mitochondrial function drops, leaving neurons underpowered. This energy shortfall maps onto the fatigue, cognitive sluggishness, and low motivation of bipolar depression. The pattern helps explain why the two mood poles feel so physiologically different: they may reflect opposite ends of a cellular energy spectrum.
A Growth Factor That Drops During Episodes
The brain constantly rewires itself, strengthening useful connections and pruning unused ones. A protein called BDNF (brain-derived neurotrophic factor) is one of the key drivers of this process. It promotes the growth of new synapses, supports the survival of existing neurons, and strengthens signal transmission between brain cells.
In bipolar disorder, BDNF levels in the blood drop significantly during both manic and depressive episodes, and the severity of the drop correlates with how severe symptoms are. When people recover and return to a stable mood, BDNF levels typically return to normal. This makes it something of a biological thermometer for mood episodes. But BDNF doesn’t just bounce back indefinitely. Over the course of the illness, baseline BDNF levels tend to decline, particularly in people who have been living with bipolar disorder for many years or who have experienced many episodes. Stressful life events and trauma further suppress BDNF production, which may partly explain why stress so reliably triggers mood episodes.
The long-term decline in BDNF helps explain a pattern clinicians call neuroprogression: the observation that for some people, episodes become more frequent and more severe over time as the brain’s capacity for repair and adaptation gradually diminishes.
Chronic Inflammation in the Brain
People with bipolar disorder show elevated levels of inflammatory signaling molecules called cytokines, both in the bloodstream and within the brain itself. Postmortem brain studies have found increased levels of key inflammatory proteins, including IL-1β and TNF-α, in the anterior cingulate cortex and prefrontal cortex, the same regions that show structural and connectivity problems.
Alongside these elevated inflammatory proteins, brain tissue from bipolar patients shows increased activation of microglia and astrocytes, the brain’s resident immune cells. When these cells are chronically activated, they release additional inflammatory molecules that can damage neurons and disrupt the blood-brain barrier, the membrane that normally keeps harmful substances out of the brain. Cerebrospinal fluid studies have confirmed elevated IL-1β in bipolar patients, indicating that this isn’t just a peripheral bloodstream issue but an active process within the central nervous system.
This chronic, low-grade neuroinflammation doesn’t just accompany bipolar disorder. It likely contributes to the progressive gray matter loss, mitochondrial damage, and declining BDNF levels described above. Inflammation, structural loss, and impaired cellular repair form a self-reinforcing loop that may drive the illness forward over time.
A Disrupted Internal Clock
The brain’s master clock sits in a small cluster of neurons in the hypothalamus called the suprachiasmatic nucleus. This clock coordinates sleep-wake cycles, hormone release, body temperature, and dozens of other biological rhythms by syncing internal processes with external cues like light and mealtimes. In bipolar disorder, this system is fundamentally unstable.
Genetic studies have identified mutations in several core clock genes in people with bipolar disorder, including CLOCK, PER3, and others that regulate the molecular gears of circadian timing. The practical effect is that the internal clock runs on a different schedule than the external world, and it shifts depending on mood state. During mania, circadian rhythms tend to advance (the internal clock runs early), with increased melatonin release. During depression, rhythms tend to delay (the clock runs late), with decreased melatonin. People with bipolar disorder are also more likely to have an “eveningness” chronotype, preferring late nights and late mornings, which itself is associated with delayed melatonin onset and greater mood instability.
Circadian disruption isn’t just a symptom of mood episodes. It can trigger them. When the internal clock falls out of sync with daily routines, travel schedules, or seasonal light changes, the resulting mismatch can destabilize mood. This is why sleep disruption is one of the most reliable early warning signs of an approaching episode.
How Treatment Changes the Brain
Lithium, one of the oldest and most effective treatments for bipolar disorder, appears to work partly by reversing some of the brain changes described above. Neuroimaging studies show that lithium accumulates in the hippocampus, a region critical for memory and mood regulation that tends to be smaller in people with bipolar disorder. People who take lithium long-term have larger hippocampal volumes than those who take other medications or no medication at all.
Laboratory research on human hippocampal cells has shown that lithium directly stimulates the production of new neurons and supporting glial cells, a process called neurogenesis. In high-dose experiments, lithium significantly increased the generation of both neuroblasts (precursors to neurons) and mature neurons compared to untreated cells. This suggests that lithium doesn’t just protect existing brain tissue. It actively promotes the growth of new cells, which could help restore hippocampal volume and improve the cognitive and emotional functions that depend on it.
This finding reframes lithium’s role: rather than simply dampening mood swings through chemical sedation, it may work in part by repairing and rebuilding the neural infrastructure that bipolar disorder erodes over time.